alpha-benzyl-n-methylphenethylamine has been researched along with ketanserin in 1 studies
*Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients. [MeSH]
*Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cadet, JL; Clark, CR; Fahn, S | 1 |
1 other study(ies) available for alpha-benzyl-n-methylphenethylamine and ketanserin
| Article | Year |
|---|---|
Behavioral effects of alpha-benzyl-N-methylphenethylamine (ABNMP), a methamphetamine analog: inhibition by ketanserin and para-chlorophenylalanine (PCPA).
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Fenclonine; Ketanserin; Male; Methamphetamine; Rats; Rats, Inbred Strains; Reaction Time | 1988 |